Erratum: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome (Pilot and Feasibility Studies(2020) 6 (52) DOI: 10.1186/s40814-020-00594-1)

Kimberly Legault; Mark Blostein; Marc Carrier; Susan Kahn; Sam Schulman; Sudeep Shivakumar; Cynthia Wu; Mark A. Crowther

doi:10.1186/s40814-020-00614-0

Erratum: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome (Pilot and Feasibility Studies(2020) 6 (52) DOI: 10.1186/s40814-020-00594-1)

Kimberly Legault, Mark Blostein, Marc Carrier, Susan Kahn, Sam Schulman, Sudeep Shivakumar, Cynthia Wu, Mark A. Crowther

科研成果: 期刊稿件 › 评论/辩论 › 同行评审

1 引用（Scopus）

源语言	英语
文章编号	67
期刊	Pilot and Feasibility Studies
卷	6
期	1
DOI	https://doi.org/10.1186/s40814-020-00614-0
出版状态	已出版 - 5月 18 2020
已对外发布	是

!!!ASJC Scopus Subject Areas

医学（杂项）

访问文件

10.1186/s40814-020-00614-0

其它文件与链接

引用此

Legault, K., Blostein, M., Carrier, M., Kahn, S., Schulman, S., Shivakumar, S., Wu, C., & Crowther, M. A. (2020). Erratum: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome (Pilot and Feasibility Studies(2020) 6 (52) DOI: 10.1186/s40814-020-00594-1). Pilot and Feasibility Studies, 6(1), 文章 67. https://doi.org/10.1186/s40814-020-00614-0

@article{f53d4fb23535437e850b33efb6b4711b,

title = "Erratum: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome (Pilot and Feasibility Studies(2020) 6 (52) DOI: 10.1186/s40814-020-00594-1)",

author = "Kimberly Legault and Mark Blostein and Marc Carrier and Susan Kahn and Sam Schulman and Sudeep Shivakumar and Cynthia Wu and Crowther, {Mark A.}",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s). Reference:.",

year = "2020",

month = may,

day = "18",

doi = "10.1186/s40814-020-00614-0",

language = "English",

volume = "6",

journal = "Pilot and Feasibility Studies",

issn = "2055-5784",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome (Pilot and Feasibility Studies(2020) 6 (52) DOI: 10.1186/s40814-020-00594-1)

AU - Legault, Kimberly

AU - Blostein, Mark

AU - Carrier, Marc

AU - Kahn, Susan

AU - Schulman, Sam

AU - Shivakumar, Sudeep

AU - Wu, Cynthia

AU - Crowther, Mark A.

PY - 2020/5/18

Y1 - 2020/5/18

UR - http://www.scopus.com/inward/record.url?scp=85086277900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086277900&partnerID=8YFLogxK

U2 - 10.1186/s40814-020-00614-0

DO - 10.1186/s40814-020-00614-0

M3 - Comment/debate

AN - SCOPUS:85086277900

SN - 2055-5784

VL - 6

JO - Pilot and Feasibility Studies

JF - Pilot and Feasibility Studies

IS - 1

M1 - 67

ER -

Erratum: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome (Pilot and Feasibility Studies(2020) 6 (52) DOI: 10.1186/s40814-020-00594-1)

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此